ARCHIVES

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Tape ready; control Program Plans for 1978 Subject Of July 15 Meeting

June 17, 1977

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

DCT Planning To Stop Use Monkeys In Preclinical Test

November 17, 1978

NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985

June 8, 1979